View Document Preview and Link Document Date: 2014-06-10 15:35:42 Open Document File Size: 150,91 KB Share Result on Facebook
City Amsterdam / Indianapolis / Reference / New York / / Company Sigma-Tau PharmaSource Inc. / Ames / Sigma-Tau Pharmaceuticals Inc. / mL / / Country United States / / / Event Product Issues / FDA Phase / / Facility PRECAUTIONS General Any laboratory / / IndustryTerm treatment of severe combined immunodeficiency disease / injection site / preservative free solution / chemical name / drug products / sterile solution / / MedicalCondition combined immunodeficiency disease / purine nucleoside phosphorylase deficiency / hemolytic anemia / chronic transfusion therapy / immune dysfunction / severe combined immunodeficiency / opportunistic infections / thrombocythemia / headache / severe combined immunodeficiency disease / recurrent infections / Carcinogenesis / thrombocytopenia / autoimmune thrombocytopenia / viral infections / ADA deficiency / primary immunodeficiency disease / inherited disease / urticaria / immune deficiency / often fatal disease / SCID / hypersensitivity / infection / adenosine deaminase deficiency / auto-immune hemolytic anemia / deficiency / MS / infections / injection site erythema / immunodeficiency disease / Hershfield MS. Immunodeficiency diseases / / MedicalTreatment red blood cell transfusions / enzyme replacement therapy / antibiotics / bone marrow transplant / / Organization Injection administration / FDA / / / Position prescribing physician / PRECAUTIONS General / physician / / Product Sodium Chloride / FS / adenosine / ADAGEN / patients / enzyme / ADAGEN® (pegademase bovine) Injection / lymphocytes / / ProvinceOrState Maryland / / Technology Pharmacokinetics / diagnostic tests / antibodies / transplantation / / URL www.fda.gov/safety/medwatch / / SocialTag 
ADAGEN® (pegademase bovine) Injection DESCRIPTION